Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZFP113 Inhibitors

ZFP113 inhibitors are a class of chemical compounds specifically designed to target zinc finger protein 113 (ZFP113), a transcription factor that regulates gene expression by binding to specific DNA sequences. Like other zinc finger proteins, ZFP113 contains zinc finger motifs, which are specialized structural domains that facilitate the protein's ability to recognize and bind to particular DNA regions. These motifs rely on the presence of zinc ions to maintain their structural integrity, ensuring that ZFP113 can interact with the DNA in a stable and specific manner. ZFP113 plays an essential role in controlling the transcription of genes, influencing various cellular processes by modulating gene expression. Inhibitors of ZFP113 function by interfering with its ability to bind DNA, either by destabilizing the zinc finger motifs or preventing the protein from accessing its target DNA sequences, ultimately leading to changes in gene regulation.

The mechanisms by which ZFP113 inhibitors work can vary based on their chemical nature. One common mechanism involves chelating the zinc ions required for the proper conformation of the zinc finger domains. By binding to these zinc ions, the inhibitors cause the zinc finger motifs to lose their structural stability, rendering ZFP113 incapable of binding to DNA. This disruption affects ZFP113's ability to regulate transcription, leading to altered expression of genes under its control. Other inhibitors may act by blocking key interactions between ZFP113 and other proteins or cofactors necessary for forming transcriptional complexes, further hindering its regulatory role. Research into ZFP113 inhibitors provides valuable insights into the function of zinc finger proteins in gene regulation, contributing to a broader understanding of transcriptional control mechanisms and the intricate genetic networks that govern cellular function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits ZNF113 expression by binding to DNA, preventing RNA polymerase from elongating.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol inhibits ZNF113 expression through its ability to modulate various signaling pathways.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin inhibits ZNF113 by affecting multiple pathways involved in gene expression and protein synthesis.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Etoposide inhibits ZNF113 expression by interfering with topoisomerase II, leading to DNA damage and repair.

Ellagic Acid, Dihydrate

476-66-4sc-202598
sc-202598A
sc-202598B
sc-202598C
500 mg
5 g
25 g
100 g
$57.00
$93.00
$240.00
$713.00
8
(1)

Ellagic acid may inhibit ZNF113 by modulating transcription factors and impacting gene expression pathways.

Berberine

2086-83-1sc-507337
250 mg
$90.00
1
(0)

Berberine inhibits ZNF113 through its ability to modulate gene expression and interfere with DNA transcription.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits ZNF113 by targeting cyclin-dependent kinases, which are involved in gene transcription.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin inhibits ZNF113 expression by trapping topoisomerase I-DNA complexes, leading to DNA damage.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Ellipticine inhibits ZNF113 expression by intercalating DNA and affecting the function of DNA topoisomerases.